The Food and Drug Administration has approved Moderna's new COVID-19 vaccine, days after the federal government tightened ...

The new vaccine is indicated for individuals who have been previously vaccinated with any COVID-19 vaccine and are 65 years or older, or 12 to 64 years of age with at least 1 underlying condition that ...

Panel members had questions about whether a new FDA proposal to require randomized trials for vaccines in healthy adults ...

In the wake of recent warnings from the Food and Drug Administration (FDA), about half of Americans think vaccines against ...

The FDA approved darolutamide (Nubeqa) for metastatic castration-sensitive prostate cancer (mCSPC). The agency previously ...

The shift indicates that critics' efforts to build support by releasing data on the harmful effects of the COVID-19 vaccines ...

Federal health officials have pulled back a key recommendation that pregnant women get the COVID-19 vaccine -- causing sharp ...

The FDA will require Moderna and Pfizer to add warnings to their COVID-19 vaccine labels about myocarditis and pericarditis in young men.

The FDA is also expanding its warning that some vaccines are linked to a risk of heart inflammation in young men.

The shot, dubbed mNexspike, is approved for older adults and people whose health conditions put them at higher risk of severe ...

The FDA approved Moderna’s new Covid-19 vaccine late Friday, though it placed restrictions on its use that the company’s ...